drugset / Trial / NCT04491916
Iron Therapy in Patients With End-Stage Renal Disease
NaSingle-groupOpen-labelTreatment
Summary
This study will compare the clinical outcome of patients with maintenance dialysis room after changing the iron treatment guidelines from original upper limit with ferritin\>500ng/ml, or TSAT\>20% to Ferritin\> 800ng / ml, or TSAT\> 50%.
Timeline
- Start
- 2020-04-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iron sucrose | Unknown | 100 mg | — |